IL73427A - 5-substituted-3-(hetero)aralkyl-oxazolidine-2-carboxylic acid esters,their preparation and pharmaceutical compositions containing them - Google Patents

5-substituted-3-(hetero)aralkyl-oxazolidine-2-carboxylic acid esters,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL73427A
IL73427A IL73427A IL7342784A IL73427A IL 73427 A IL73427 A IL 73427A IL 73427 A IL73427 A IL 73427A IL 7342784 A IL7342784 A IL 7342784A IL 73427 A IL73427 A IL 73427A
Authority
IL
Israel
Prior art keywords
oxazolidine
hetero
aralkyl
substituted
preparation
Prior art date
Application number
IL73427A
Other languages
English (en)
Other versions
IL73427A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6070/83A external-priority patent/CH655931A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL73427A0 publication Critical patent/IL73427A0/xx
Publication of IL73427A publication Critical patent/IL73427A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL73427A 1983-11-10 1984-11-05 5-substituted-3-(hetero)aralkyl-oxazolidine-2-carboxylic acid esters,their preparation and pharmaceutical compositions containing them IL73427A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6070/83A CH655931A5 (en) 1983-11-10 1983-11-10 Oxazolidines
CH449984 1984-09-20

Publications (2)

Publication Number Publication Date
IL73427A0 IL73427A0 (en) 1985-02-28
IL73427A true IL73427A (en) 1988-02-29

Family

ID=25695620

Family Applications (1)

Application Number Title Priority Date Filing Date
IL73427A IL73427A (en) 1983-11-10 1984-11-05 5-substituted-3-(hetero)aralkyl-oxazolidine-2-carboxylic acid esters,their preparation and pharmaceutical compositions containing them

Country Status (22)

Country Link
US (2) US4743604A (no)
AT (1) AT387771B (no)
AU (1) AU576531B2 (no)
BE (1) BE900983A (no)
CA (1) CA1249992A (no)
DE (1) DE3438411A1 (no)
DK (1) DK520584A (no)
ES (1) ES8606863A1 (no)
FI (1) FI844152L (no)
FR (1) FR2554814B1 (no)
GB (1) GB2149405B (no)
HU (1) HU193465B (no)
IL (1) IL73427A (no)
IT (1) IT1177033B (no)
LU (1) LU85631A1 (no)
MC (1) MC1641A1 (no)
NL (1) NL8403308A (no)
NO (1) NO844501L (no)
NZ (1) NZ210105A (no)
PH (1) PH22462A (no)
PT (1) PT79485B (no)
SE (1) SE463099B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968707A (en) * 1987-06-10 1990-11-06 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
FI892341A (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
SK111195A3 (en) * 1994-09-13 1997-06-04 Sandoz Technology Ltd Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
US7822452B2 (en) 2004-08-11 2010-10-26 Glt Acquisition Corp. Method for data reduction and calibration of an OCT-based blood glucose monitor
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8768423B2 (en) * 2008-03-04 2014-07-01 Glt Acquisition Corp. Multispot monitoring for use in optical coherence tomography
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA979912A (en) * 1970-06-22 1975-12-16 Frederic P. Hauck Tetrahydronaphthyloxyaminopropanols and related compounds
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES

Also Published As

Publication number Publication date
PT79485B (en) 1987-01-13
IT8423307A0 (it) 1984-10-25
ES8606863A1 (es) 1986-05-01
PT79485A (en) 1984-12-01
SE8405632L (sv) 1985-05-11
DE3438411A1 (de) 1985-05-30
AU3527584A (en) 1985-05-16
SE8405632D0 (sv) 1984-11-09
GB8428335D0 (en) 1984-12-19
HU193465B (en) 1987-10-28
FR2554814A1 (fr) 1985-05-17
AT387771B (de) 1989-03-10
IL73427A0 (en) 1985-02-28
DK520584D0 (da) 1984-11-01
HUT36103A (en) 1985-08-28
MC1641A1 (fr) 1986-01-09
GB2149405A (en) 1985-06-12
US4743604A (en) 1988-05-10
PH22462A (en) 1988-09-12
AU576531B2 (en) 1988-09-01
GB2149405B (en) 1987-07-01
ES537487A0 (es) 1986-05-01
BE900983A (fr) 1985-05-06
US4871755A (en) 1989-10-03
LU85631A1 (fr) 1986-06-04
FI844152A0 (fi) 1984-10-22
CA1249992A (en) 1989-02-14
DK520584A (da) 1985-05-11
IT8423307A1 (it) 1986-04-25
ATA355384A (de) 1988-08-15
IT1177033B (it) 1987-08-26
FI844152L (fi) 1985-05-11
SE463099B (sv) 1990-10-08
FR2554814B1 (fr) 1988-03-11
NZ210105A (en) 1988-10-28
NL8403308A (nl) 1985-06-03
NO844501L (no) 1985-05-13

Similar Documents

Publication Publication Date Title
IL69347A0 (en) Methylene-diphosphonic acid derivatives,their preparation and pharmaceutical compositions containing them
IL69601A0 (en) Naphthyridine-,quinoline-and benzoxazine-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL76453A0 (en) Isoxazolecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
SG6885G (en) 2-hydroxy-5-phenylazobenzoic acid derivatives and pharmaceutical compositions containing them
IL84766A0 (en) Phosphinic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL69081A0 (en) Benzoic acid piperidyl ester derivatives,their preparation and pharmaceutical compositions containing them
IL73125A0 (en) 1-benzyl-aminoalkyl-pyrrolidinones and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
IL56991A (en) 4-halo-3-oxoandrost-4-ene-17 beta-thiocarboxylic acid esters,their preparation and pharmaceutical compositions containing them
PH17338A (en) Substituted azabicyclo-octane-carboxylic acids,their preparation and pharmaceutical compositions containing them
IL73427A (en) 5-substituted-3-(hetero)aralkyl-oxazolidine-2-carboxylic acid esters,their preparation and pharmaceutical compositions containing them
IL68323A0 (en) Phenoxyalkylcarboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL79025A0 (en) Quinolonecarboxylic acid esters,their preparation and pharmaceutical compositions containing them
IL67929A (en) 1-methyl-5-p-toluoylpyrrole-2-acetic acid amides,their preparation and pharmaceutical compositions comprising them
IL64732A0 (en) Carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL83049A (en) 4-quinolinone-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
AU537560B2 (en) Phenyl-alkanoic acid derivatives and their preparation and pharmaceutical compositions containing them
IL72157A (en) 6-alpha-hydroxyethyl-2-substituted-2-penem-3-carboxylic acid derivatives and pharmaceutical compositions comprising them
IL59514A (en) 6beta-iodo-substituted penicillanic acid and esters,their preparation and pharmaceutical compositions containing them
IL75913A (en) Phenyl-nonatetraenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL87130A0 (en) Hydrocinnamic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL71525A0 (en) Niflumic acid morpholinoethyl ester diniflumate,its preparation and pharmaceutical compositions containing it
IL69172A0 (en) Phenylacetic acid derivatives,their preparation and pharmaceutical compositions containing them
IL71657A0 (en) Substituted piperazin-1-yl-acetic acid amides,their preparation and pharmaceutical compositions containing them
IL75775A0 (en) Aminoeburnanecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL72079A (en) 4-benzoyl-5-hydroxy-1-benzocyclobutenecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them